Trials / Conditions / Aggressive Fibromatosis
Aggressive Fibromatosis
6 registered clinical trials studyying Aggressive Fibromatosis — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Nirogacestat in Premenopausal Females With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) NCT07176689 | SpringWorks Therapeutics, Inc. | Phase 4 |
| Active Not Recruiting | A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) NCT07170644 | SpringWorks Therapeutics, Inc. | Phase 2 |
| Completed | Nirogacestat for Adults With Desmoid Tumor/Aggressive Fibromatosis (DT/AF) NCT03785964 | SpringWorks Therapeutics, Inc. | Phase 3 |
| Active Not Recruiting | National Clinical-biological Prospective Cohort of Incident Cases of Aggressive Fibromatosis (ALTITUDES) NCT02867033 | Centre Oscar Lambret | N/A |
| Completed | Phase II Trial of the Gamma-Secretase Inhibitor PF-03084014 in Adults With Desmoid Tumors/Aggressive Fibromato NCT01981551 | National Cancer Institute (NCI) | Phase 2 |
| Completed | Study to Evaluate Imatinib in Desmoid Tumors NCT01137916 | Heidelberg University | Phase 2 |